Nu Skin/$NUS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nu Skin
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Ticker
$NUS
Sector
Primary listing
NYSE
Employees
3,100
Headquarters
Website
Nu Skin Metrics
BasicAdvanced
$587M
5.84
$2.03
0.89
$0.24
2.02%
Price and volume
Market cap
$587M
Beta
0.89
52-week high
$12.41
52-week low
$5.32
Average daily volume
607K
Dividend rate
$0.24
Financial strength
Current ratio
2.013
Quick ratio
1.145
Long term debt to equity
36.104
Total debt to equity
39.446
Dividend payout ratio (TTM)
11.83%
Interest coverage (TTM)
5.27%
Profitability
EBITDA (TTM)
156.845
Gross margin (TTM)
69.61%
Net profit margin (TTM)
6.20%
Operating margin (TTM)
5.89%
Effective tax rate (TTM)
14.19%
Revenue per employee (TTM)
$520,000
Management effectiveness
Return on assets (TTM)
3.95%
Return on equity (TTM)
13.68%
Valuation
Price to earnings (TTM)
5.844
Price to revenue (TTM)
0.362
Price to book
0.75
Price to tangible book (TTM)
0.89
Price to free cash flow (TTM)
10.046
Free cash flow yield (TTM)
9.95%
Free cash flow per share (TTM)
1.181
Dividend yield (TTM)
2.02%
Forward dividend yield
2.02%
Growth
Revenue change (TTM)
-11.79%
Earnings per share change (TTM)
-167.83%
3-year revenue growth (CAGR)
-13.12%
10-year revenue growth (CAGR)
-3.62%
3-year earnings per share growth (CAGR)
-2.94%
10-year earnings per share growth (CAGR)
-4.59%
3-year dividend per share growth (CAGR)
-46.07%
10-year dividend per share growth (CAGR)
-16.11%
What the Analysts think about Nu Skin
Analyst ratings (Buy, Hold, Sell) for Nu Skin stock.
Nu Skin Financial Performance
Revenues and expenses
Nu Skin Earnings Performance
Company profitability
Nu Skin News
AllArticlesVideos
Stonegate Capital Partners Initiates Coverage on NU Skin Enterprises Inc. (NUS)
Newsfile Corp1 month ago
Nu Skin Enterprises to Announce Second Quarter 2025 Financial Results
Business Wire2 months ago
Nu Skin Expands and Repackages ageLOC® Tru Face® Line, Setting a New Standard for Sustainable Skincare
Business Wire3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Nu Skin stock?
Nu Skin (NUS) has a market cap of $587M as of September 18, 2025.
What is the P/E ratio for Nu Skin stock?
The price to earnings (P/E) ratio for Nu Skin (NUS) stock is 5.84 as of September 18, 2025.
Does Nu Skin stock pay dividends?
Yes, the Nu Skin (NUS) stock pays dividends to shareholders. As of September 18, 2025, the dividend rate is $0.24 and the yield is 2.02%. Nu Skin has a payout ratio of 11.83% on a trailing twelve-month basis.
When is the next Nu Skin dividend payment date?
The next Nu Skin (NUS) dividend payment date is unconfirmed.
What is the beta indicator for Nu Skin?
Nu Skin (NUS) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.